Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novartis synthesizes mTORC1 inhibitors

Aug. 4, 2020

Nanjing TransThera Biosciences identifies AOC3 inhibitors

Aug. 4, 2020

Cadila Healthcare patents NLRP3 inflammasome inhibitors

Aug. 4, 2020

Genentech opens phase I study of GDC-6036 KRAS G12C mutation solid tumors

Aug. 4, 2020

Rozlytrek approved in E.U. for NTRK fusion solid tumors and for ROS1-positive advanced NSCLC

Aug. 3, 2020

Phase Ib efficacy assessment of ETC-159 begins in patients with cancer

Aug. 3, 2020

Accro Bioscience patent describes necrosis inhibitors

Aug. 3, 2020

Calithera Biosciences identifies arginase inhibitors

Aug. 3, 2020

Theralase updates on phase II study of TLD-1433 plus TLC-3200 in non-muscle-invasive bladder cancer

Aug. 3, 2020

Phenex-FXR patents new oxysterol receptor inverse agonists

Aug. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...